43 results on '"Luan, Xiaohui"'
Search Results
2. Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis
3. Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
4. Wave optics simulation investigation of multiple-input and aperture-averaging for optical wave propagation in turbulent ocean
5. Multiparameter diagnostic model based on 18F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma
6. Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy
7. The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy
8. Can 18F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study
9. BMI-1 activates hepatic stellate cells to promote EMT of colorectal cancer cells
10. A Preclinical Study of an 125I-Labeled PSMA Ligand for Prostate-Cancer Puncture
11. 18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer
12. Pretreatment Metabolic Parameters Measured by 18F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C
13. The value of pretreatment 18F-FDG PET/CT to predict the pathological treatment response of hepatocellular carcinoma patients treated with PD-1 inhibitors and lenvatinib as a conversion therapy in BCLC stage C.
14. Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis.
15. A Preclinical Study of an 125 I-Labeled PSMA Ligand for Prostate-Cancer Puncture.
16. Tumor Angiogenesis at Baseline Identified by 18F-Alfatide II PET/CT May Predict Survival Among Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
17. Pretreatment Metabolic Parameters Measured by 18F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C.
18. Lymph Node Maximum Uptake of 18F-ALF-NOTA-PRGD2 II PET/CT Predicts Lung Cancer Survival
19. Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
20. 18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer
21. Scintillation index of an optical wave propagating through moderate-to-strong oceanic turbulence
22. Study on the wave structure function and spatial coherence radius with a power-law spectrum of oceanic turbulence
23. Beam-wander analysis in turbulent ocean with the effect of the eddy diffusivity ratio and the outer scale
24. Underwater optical communication performance under the influence of the eddy diffusivity ratio
25. The comparison of 18F-alfatide PET/CT and 18F-FDG PET/CT in predicting chemoradiotherapy sensitivity in patients with advanced non-small cell lung cancer.
26. Underwater optical communication performance under the influence of the eddy diffusivity ratio
27. Notice of Retraction: Research on the Gray Calamity Forecasting of the Enterprise's Stock Demand Based on GM (1,1)
28. F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.
29. The Study of Cluster Predication Method on Sales Forecast Based on Residual Error Modified GM (1, 1)
30. The Application of Weight Allocation Delphi in the Enterprises' Operation Evaluation and Empirical Work
31. Association study of the polymorphisms in the KISS1 gene with central precocious puberty in Chinese girls
32. A modified simple RFLP-PCR method for single nucleotide polymorphism (SNP) typing
33. Association study of four activity SNPs of CYP3A4 with the precocious puberty in Chinese girls
34. Research on the Gray Calamity Forecasting of the Enterprise's Stock Demand Based on GM (1,1).
35. Ross Terrill's China Story.
36. Metabolic parameters of pretreatment 2-[ 18 F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort study.
37. Multiparameter diagnostic model based on 18 F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
38. Corrigendum: The role of 18F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.
39. The role of 18 F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.
40. Can 18 F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?-A single-center retrospective study.
41. Pretreatment Metabolic Parameters Measured by 18 F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C.
42. 18 F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer.
43. Association study of six activity SNPS in adrenal steroid hormone metabolism and IBM related genes with precocious puberty in Chinese girls.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.